Alexandra has dedicated her life to the improvement of health and medicine and co-founded Apollo with Nils and Ole in 2017. She is a Venture Partner at Apollo.
She is deeply involved in Apollo’s Venture Lab where she focused on identifying company building opportunities through her close ties with global leading research institutes and researchers in the aging sector
Alexandra worked in BCG’s healthcare practice specializing in biopharma strategy, market assessment and asset diligence
She did her PhD studies at Harvard Medical School focusing on molecular mechanisms that contribute to cellular aging and is a trained pharmacist
Alexandra has dedicated her life to the improvement of health and medicine and co-founded Apollo with Nils and Ole in 2017. She is a Venture Partner at Apollo.
She is deeply involved in Apollo’s Venture Lab where she focused on identifying company building opportunities through her close ties with global leading research institutes and researchers in the aging sector
Alexandra worked in BCG’s healthcare practice specializing in biopharma strategy, market assessment and asset diligence
She did her PhD studies at Harvard Medical School focusing on molecular mechanisms that contribute to cellular aging and is a trained pharmacist
